toradol
PreclinicalSmall molecule
toradol is one of 61 small molecule programs targeting Renal Colic. It is currently in Preclinical.
2
Indications
10
Total Trials
0
Active Trials
60
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
67 competitors in Total Knee Arthroplasty
#DrugCompanyPhaseTrials
1Naropin
FFresenius Kabi USA, LLC
Approved
Cyklokapron
JJ Molner
Approved
Marcaine
IInnocoll
Approved
Decadron
AAspen Global Incorporated
Approved
Medrol
PfizerApproved
Carbocaine
PfizerApproved
Journavx
Vertex PharmaceuticalsApproved
Lexapro
AbbVieApproved
MS Contin
HHikma Pharmaceuticals LLC
Approved
Celebrex
PPhiladelphia Eye Associates
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Renal Colic1 trial
An Analgesia Protocol for Acute Renal Colic in the Emergency Department
Completed·—·N/A·NCT00504283·45 enrolled
Efficacy1 trial
5 more indications
Total Knee Arthroplasty1 trial
Ankle Surgery1 trial
Spinal Fusion1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for toradol. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details